about
Potentiation of the adverse effects of intravenous terbutaline by oral theophylline.Arrhythmogenic potential of diuretic induced hypokalaemia in patients with mild hypertension and ischaemic heart diseaseSotalol, hypokalaemia, syncope, and torsade de pointesManagement of mild hypertension. Selecting an antihypertensive regimen.Empiric potassium supplementation and increased survival in users of loop diuretics.Electrocardiographic findings and frequency of arrhythmias in Bartter's syndrome.Medical evaluation before operation.Hypoglycaemia and associated hypokalaemia in diabetes: mechanisms, clinical implications and prevention.Hydrochlorothiazide-amiloride versus hydrochlorothiazide alone for essential hypertension: effects on blood pressure and serum potassium levelHypokalemia and sudden cardiac death.Cardiovascular and biochemical responses to nebulised salbutamol in normal subjectsIndapamide-induced severe hyponatremia and hypokalemia.Diuretic-related side effects: development and treatment.Diuretics should continue to be one of the preferred initial therapies in the management of hypertension: the argument for.Potassium, magnesium, and electrolyte imbalance and complications in disease management.Treatment of arrhythmia in patients with heart failure.A study of two diuretic/potassium combinations in heart failure.Effects of enalapril in heart failure: a double blind study of effects on exercise performance, renal function, hormones, and metabolic state.Strategies to improve the cardiovascular risk profile of thiazide-type diuretics as used in the management of hypertension.Metabolic side effects and cardiovascular events of diuretics: should a diuretic remain the first choice therapy in hypertension treatment? The case of yes.Nutrition and heart failure: impact of drug therapies and management strategies.Diuretics in clinical practice. Part II: electrolyte and acid-base disorders complicating diuretic therapy.Diuretics in the treatment of hypertension. Part 1: thiazide and thiazide-like diuretics.Ventricular fibrillation and initial plasma potassium in acute myocardial infarction.Enalapril: a long-acting angiotensin-converting enzyme inhibitor.Role of abnormal repolarization in the mechanism of cardiac arrhythmia.Initial therapy for mild hypertension.UCLA geriatric grand rounds. Hypertension in the elderly.Diuretics: mechanisms of action and uses.A decade of developments in diuretic drug therapy.Current approaches to management of potassium deficiency.Retrospective analyses for hypothesis generation. A commentary on the PACK trial (prevention of atherosclerotic complications with ketanserin).Electrophysiological impact of diuretics in heart failureTotal body electrolyte composition in patients with heart failure: a comparison with normal subjects and patients with untreated hypertension.Results of the ALLHAT trial: is the debate about initial antihypertensive drug therapy over?Metabolic and blood pressure effects of angiotensin converting enzyme inhibitors in mild-to-moderate American hypertensives.The impact of serum potassium-influencing antihypertensive drugs on the risk of out-of-hospital cardiac arrest: A case-control study.Hypertension: a view from Detroit.Chamber-specific effects of hypokalaemia on ventricular arrhythmogenicity in isolated, perfused guinea-pig heart
P2860
Q28362021-65107009-39B4-4039-AB73-BA1F5786067BQ28362616-2A0BC5FB-07D5-44F2-B31D-0EC9D33E0CB1Q28365910-B6349A88-1913-470D-A6E0-5EA3A38D101CQ33558825-DA59069D-594B-4E19-B05E-5647E558288CQ33910812-A4E9EE8D-0781-4709-9C3A-0CE4224D4B9FQ33999995-04F3E896-9BB3-49E5-A656-3EA7D7D03531Q34112422-76B8834A-AB81-4B83-845B-361807AA77A1Q34163348-05A95B2C-7FB3-48E1-BC18-D2FCF77753A4Q34299089-DD13BA5F-0D97-419F-A6A9-A4F9983CF751Q34467063-9EE13B19-89C8-452B-B9C2-32F72701096DQ34621827-DC610EA4-B07A-48A2-B07C-78CF6ACEB295Q34732574-610EFA87-8B0F-4E39-9E2E-1B0F6368B968Q35886396-5A9BE4DC-6510-4512-87DF-97A5F0FA3EADQ36050023-53DA69BA-23B7-41C0-8C24-A7329A356167Q36072932-FF4C9347-B838-418D-993F-A914F0432781Q36616376-A5A0EDA4-DCD5-48A3-8BC2-88C5E682582EQ36705893-C47BB657-DDB7-4083-955D-2093888F1990Q36760112-9D7BD155-DFDD-4224-BF2C-D1470CF87490Q36945027-6705E7E5-0A2F-4773-8946-1F6CA1A2946EQ37024082-270F20A5-8A4C-4756-9ECB-D013CD4CF991Q37401599-9A024252-E4A5-4FE7-9E1E-E56C0D46C5F0Q37679929-B1E25FEA-E6B1-4C9E-8E29-7879A20F8BE5Q38180204-65995ED5-308A-4808-B653-84CBDB6FFE99Q38929277-DBA981DF-8627-4D22-879F-1A539827F1EDQ39177686-7557B462-1874-434A-89B4-ED11444222BBQ39434566-BE24724A-9397-452F-B445-2AE603D8E134Q39447236-4BDD5270-7C89-480D-ADC3-02737C72B8ADQ39468548-BC7A9045-AE64-4E68-86B0-E60603EC010DQ39598380-A6A50ECE-7ADB-43DC-9702-E3E1F4479C84Q39752079-82E1706C-7AC2-4EC7-96C9-BE6179684E07Q39816356-BCAC9F27-3D5E-4D92-9FF4-B0E89EABBE5FQ41297627-2B568E43-F63B-4AD0-8660-BE989F114B55Q41828900-6B19ECDB-BF03-46F7-B2FA-BB8A85430CC3Q42978754-10A64492-B6D7-4556-B143-CD9D7E19E5FBQ44295766-5A9AD703-E0A9-4DF2-88E7-3C5B8863DB50Q46382940-9CE76ACB-C8E8-4BB6-9932-7BB10AF530D5Q48199679-0E93A01F-CB1D-46FD-87B0-9C8E81A0C087Q53880216-743145EB-7DAD-4B18-B3EB-D34BEC9F278EQ57100516-C3D7068C-084F-4864-90C7-8D634F39F70D
P2860
description
1981 nî lūn-bûn
@nan
1981年の論文
@ja
1981年論文
@yue
1981年論文
@zh-hant
1981年論文
@zh-hk
1981年論文
@zh-mo
1981年論文
@zh-tw
1981年论文
@wuu
1981年论文
@zh
1981年论文
@zh-cn
name
Diuretic-induced ventricular ectopic activity.
@en
Diuretic-induced ventricular ectopic activity.
@nl
type
label
Diuretic-induced ventricular ectopic activity.
@en
Diuretic-induced ventricular ectopic activity.
@nl
prefLabel
Diuretic-induced ventricular ectopic activity.
@en
Diuretic-induced ventricular ectopic activity.
@nl
P2093
P1476
Diuretic-induced ventricular ectopic activity.
@en
P2093
P304
P356
10.1016/0002-9343(81)90530-1
P407
P577
1981-04-01T00:00:00Z